Skip to main content
. Author manuscript; available in PMC: 2011 Jul 19.
Published in final edited form as: Neurology. 1992 Jun;42(6):1171–1175. doi: 10.1212/wnl.42.6.1171

Table 1.

Characteristics of patients with MIS

No. Age/Sex (mo) Etiology Time (hr) CRH (pg/ml) ACTH (pg/ml) Cortisol (ng/ml) IL-1 (pg/ml)
1 3.5/M Congenital CMV 4 PM 30 1.04
2 10/M Cryptogenic (DD) 9 PM 70 0.96 16
3 8/M Cryptogenic (NL) 10 AM 56 1.24
4 5.5/F Cryptogenic (NL) 7 PM 65 40
5 7/F Meningitis 11 AM 37 51 1.28 15
6 6/F Congenital malformation 8 AM 45 27 1.30 ND
7 6/M Down’s syndrome 12 PM 26 18 1.76 ND
8 3/M Cryptogenic (DD) 4 PM 55 25 0.96
9 5/F Neurodegenerative disease 4 PM 50 21 2.00
10 6/F Cryptogenic (DD) 3 PM 41 38 1.72
11 12/M Hydrocephalus 1 PM 32 21 1.36
12 4/F Cryptogenic (NL) 9 AM 20 ND
13 5/F Congenital hydrocephalus 6 PM 36 1.15 ND
14 11/M Congenital malformation 10 PM 37 0.50

DD Developmentally delayed.

NL Normal development.

ND Nondetectable.